Analysis of the epidemiological characteristics of national reported pulmonary tuberculosis incidence, 1997—2023

doi:10.19982/j.issn.1000-6621.20240382

Abstract

Abstract:

Objective: To systematically description and analyze the epidemiological characteristics of reported cases of pulmonary tuberculosis (TB) in China from 1997 to 2023, and to provide scientific evidences for development and improvement of TB prevention and control strategies in China. Methods: The incidence data of pulmonary TB from 1997 to 2023 were collected from the National Epidemic Data Collection, Disease Surveillance and Statistics Report, and Infectious Disease Reporting Information Management System. The temporal and spatial trends of reported incidence of pulmonary TB in the whole country and various regions, the distribution characteristics of different gender, age and occupation group,and the positive rate of etiology in TB patients were analyzed. Results: From 1997 to 2023, a total of 21.9066 million pulmonary TB cases were reported in China, increasing from 418234 in 1997 to 1259308 in 2005, and then decreasing to 613091 in 2023. From 2005 to 2023, the reported incidence rate of pulmonary TB showed an decreasing trend (AAPC=-4.78%, 95%CI: -5.44% to -4.13%, P<0.001), and the decline was slower in the western region (AAPC=-4.42%, 95%CI: -5.77% to -2.89%, P<0.001). From 1997 to 2023, the male-to-female ratio of reported TB cases in China was 2.22∶1, the proportion of children younger than 15 years showed a decreasing trend (AAPC=-5.74%, 95%CI: -6.01% to -5.50%, P<0.001), and the proportion of elderly aged ≥65 years showed an increasing trend (AAPC=3.80%, 95%CI: 3.61% to 3.99%, P<0.001). The top five occupations reporting the number of cases were farmers, animal keepers and fishermen (61.50%,13421197/21822416), homemakers and unemployed persons (9.32%,2033078/21822416), workers (5.89%,1285335/21822416), students (5.44%,1186104/21822416) and retired persons (4.69%,1022406/21822416). The etiological positive rate of reported TB patients in 2023 was 67.08%(392569/585187). Conclusion: Since 1997, the reported incidence of pulmonary TB in China increased first and then decreased, reflecting the effect of effective TB prevention and control measures in different periods. In the future, different strategies should be implemented according to the epidemic characteristics of TB in different regions and populations, and the application of new technologies and measures should be promoted to accelerate the end of the TB epidemic.

Key words: Tuberculosis, pulmonary, Incidence, Epidemiologic studies

CLC Number:

R521

Song Yuanyuan, Li Tao, Xia Hui, Zhang Lijie, Zhang Hui, Zhao Yanlin, Wang Lixia. Analysis of the epidemiological characteristics of national reported pulmonary tuberculosis incidence, 1997—2023[J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1198-1208. doi: 10.19982/j.issn.1000-6621.20240382

Figures/Tables 6

References 85

[1]	World Health Organization.Global Tuberculosis Report 2023. Geneva: World Health Organization, 2023.
[2]	舒薇, 刘宇红. 世界卫生组织《2023年全球结核病报告》解读. 结核与肺部疾病杂志, 2024, 5(1): 15-19. doi:10.19983/j.issn.2096-8493.2024006.
[3]	World Health Organization. The end TB strategy. Geneva: World Health Organization, 2015.
[4]	中华人民共和国卫生部. 关于进一步加强全国结核病防治工作的通知. 卫疾控发〔1996〕第5号.1996-02-05.
[5]	中华人民共和国国家卫生和计划生育委员会. 国家卫生计划生育委员会关于调整肺结核传染病报告分类的通知. 国卫办疾控函〔2017〕600号.2017-06-15.
[6]	中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 结核与肺部疾病杂志, 2024, 5(4): 376-378. doi:10.19983/j.issn.2096-8493.2024022.
[7]	中华人民共和国国家卫生和计划生育委员会. WS 196—2017 结核病分类. 结核与肺部疾病杂志, 2024, 5(4): 379-380. doi:10.19983/j.issn.2096-8493.2024055.
[8]	中华人民共和国国家卫生健康委员会. 国家卫生健康委办公厅关于调整肺结核传染病报告分类的通知. 国卫办疾控函〔2019〕296号.2019-03-21.
[9]	全国第五次结核病流行病学抽样调查技术指导组,全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012, 34(8):485-508.
[10]	杨寒雨, 赵晓永, 王磊. 数据归一化方法综述. 计算机工程与应用, 2023, 59(3):13-22. doi: 10.3778/j.issn.1002-8331.2207-0179
[11]	World Health Organization. TB impact measurement policy and recommendations for how to assess the epidemiological burden of TB and the impact of TB control. Geneva: World Health Organization, 2009.
[12]	Wang L, Liu J, Chin DP. Progress in tuberculosis control and the evolving public-health system in China. Lancet, 2007, 369(9562): 691-696. doi:10.1016/S0140-6736(07)60316-X. pmid: 17321314
[13]	张文康. 在全国结核病防治工作电视电话会议上的讲话. 中国防痨杂志, 2001, 23(2): 71-77.
[14]	李涛, 杜昕, 陈伟, 等. 中国结核病管理信息监测与监控的回顾与展望. 中国防痨杂志, 2020, 42(7): 657-661. doi:10.3969/j.issn.1000-6621.2020.07.003.
[15]	马家奇, 杨功焕, 施晓明. 基于IT技术平台的中国疾病监测. 疾病监测, 2006, 21(1): 1-4.
[16]	王黎霞, 姜世闻. 我国结核病控制策略的发展与展望. 中国防痨杂志, 2014, 36(8): 630-633. doi:10.3969/j.issn.1000-6621.2014.08.002.
[17]	姜世闻, 张慧, 王冬梅, 等. 全球基金结核病项目对中国结核病控制的贡献. 中国防痨杂志, 2014, 36(5): 305-307. doi:10.3969/j.issn.1000-6621.2014.05.001.
[18]	肖东楼. 全国结核病防治规划(2001—2010年)终期评估报告. 北京: 军事医学科学出版社,2011.
[19]	Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990— 2010; a longitudinal analysis of national survey data. Lancet,2014, 383(9934):2057-2064. doi:10.1016/S0140-6736(13)62639-2.
[20]	World Health Organization. Global tuberculosis control:WHO report 2011. Geneva: World Health Organization, 2011.
[21]	Dye C, Maher D, Weil D, et al. Targets for global tuberculosis control. Int J Tuberc Lung Dis, 2006, 10(4):460-462. pmid: 16602414
[22]	World Health Organization. Global tuberculosis report 2007. Genven: World Health Organization, 2007.
[23]	World Health Organization. Global Tuberculosis Report 2020. Geneva: World Health Organization, 2020.
[24]	中华人民共和国卫生部, 中华人民共和国国家计划委员会, 中华人民共和国财政部. 国务院办公厅关于印发全国结核病防治规划(2001—2010年)的通知.国办发〔2001〕75号.2001-10-13.
[25]	中华人民共和国国务院办公厅. 国务院办公厅关于印发全国结核病防治规划(2011—2015年)的通知.国办发〔2011〕53号.2011-11-17.
[26]	中华人民共和国国务院办公厅. 国务院办公厅关于印发“十三五”全国结核病防治规划的通知.国办发〔2017〕16号.2017-02-01.
[27]	中华人民共和国国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020年版)的通知.国卫办疾控函〔2020〕279号.2020-04-02.
[28]	Dong Z, Wang QQ, Yu SC, et al. Age-period-cohort analysis of pulmonary tuberculosis reported incidence, China, 2006—2020. Infect Dis Poverty,2022, 11(1):85. doi:10.1186/s40249-022-01009-4.
[29]	Huang F, Cheng S, Du X, et al. Electronic recording and reporting system for tuberculosis in China: experience and opportunities. J Am Med Inform Assoc, 2014, 21(5):938-941. doi:10.1136/amiajnl-2013-002001. pmid: 24326537
[30]	Wang L, Cheng S, Xu M, et al. Model collaboration between hospitals and public health system to improve tuberculosis control in China. Int J Tuberc Lung Dis, 2009, 13(12):1486-1492. pmid: 19919765
[31]	Wang L, Liu X, Huang F, et al. Engaging hospitals to meet tuberculosis control targets in China: using the Internet as a tool to put policy into practice. Bull World Health Organ, 2010, 88(12):937-942. doi:10.2471/BLT.09.071753.
[32]	中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 中华人民共和国教育部, 等. 关于印发遏制结核病行动计划(2019—2022年)的通知.国卫疾控发〔2019〕41号. 2019-05-31.
[33]	中国疾病预防控制中心结核病预防控制中心. 中国结核病防治工作技术指南. 北京: 人民卫生出版社, 2021.
[34]	中国疾病预防控制中心结核病预防控制中心. 中国结核病防治工作技术考核手册. 北京: 人民卫生出版社, 2021.
[35]	中国疾病预防控制中心结核病预防控制中心. 中国结核病防治综合质量控制核查手册. 北京: 人民卫生出版社, 2022.
[36]	徐彩红, 赵雁林. 构建智慧化网络助力结核病防治. 中国防痨杂志, 2022, 44(3): 215-218. doi:10.19982/j.issn.1000-6621.20210724.
[37]	王云霞, 孟庆琳, 刘二勇, 等. 我国结核病关爱行动试点项目基线调查分析. 中国防痨杂志, 2024, 46(3): 325-332. doi:10.19982/j.issn.1000-6621.20230359.
[38]	成君, 赵雁林. 无结核社区建设中的主动筛查策略. 中国防痨杂志, 2024, 46(6): 605-612. doi:10.19982/j.issn.1000-6621.20230435.
[39]	Mane SS, Shrotriya P. Current Epidemiology of Pediatric Tuberculosis. Indian J Pediatri, 2024, 91(7): 711-716. doi:10.1007/s12098-023-04910-4.
[40]	沈鑫, 沙巍, 刘剑君. 新型冠状病毒肺炎疫情对结核病防控的影响及对策. 中国防痨杂志, 2020, 42(6):544-548. doi:10.3969/j.issn.1000-6621.2020.06.003.
[41]	Fei H, Yin X, Hui C, et al. The impact of the COVID-19 epidemic on tuberculosis control in China. Lancet Reg Health West Pac, 2020, 3:100032. doi:10.1016/j.lanwpc.2020.100032.
[42]	Li T, Du X, Kang JJ, et al. Patient, diagnosis, and treatment delays among tuberculosis patients before and during COVID-19 epidemic-China, 2018—2022. China CDC Wkly, 2023, 5(12):259-265. doi:10.46234/ccdcw2023.047.
[43]	沈鑫, 沙巍, 刘剑君. 新型冠状病毒肺炎疫情对结核病防控的影响及对策. 中国防痨杂志, 2020, 42(6):544-548. doi:10.3969/j.issn.1000-6621.2020.06.003.
[44]	Xu CH, Li T, Hu DM, et al. Predicted impact of the COVID-19 responses on deaths of tuberculosis-China, 2020. China CDC Wkly, 2021, 3(2):21-24. doi:10.46234/ccdcw2021.004.
[45]	王歆尧, 姜美丽, 庞元捷, 等. 中国结核病疾病负担现状. 中华流行病学杂志, 2024, 45(6):857-864. doi:10.3760/cma.j.cn112338-20240311-00111.
[46]	张燕, 王森路, 日孜宛古力·热合曼, 等. 新疆维吾尔自治区和田地区“肺结核主动筛查+全疗程住院治疗”模式对患者发现的效果. 中国防痨杂志, 2024, 46(2): 145-150. doi:10.19982/j.issn.1000-6621.20230284.
[47]	Nhamoyebonde S, Leslie A. Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis, 2014, 209 Suppl 3:S100-S106. doi:10.1093/infdis/jiu147.
[48]	Borgdorff MW, Nagelkerke NJ, Dye C, et al. Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection. Int J Tuberc Lung Dis, 2000, 4(2):123-132. pmid: 10694090
[49]	Rees D, Murray J. Silica, silicosis and tuberculosis. Int J Tuberc Lung Dis, 2007, 11(5):474-484. pmid: 17439668
[50]	中华人民共和国国家卫生健康委员会. 中国吸烟危害健康报告(2020).2021-05-28.
[51]	Narasimhan P, Wood J, Macintyre CR, et al. Risk factors for tuberculosis. Pulm Med, 2013:828939. doi:10.1155/2013/828939.
[52]	Wilsnack RW, Wilsnack SC, Kristjanson AF, et al. Gender and alcohol consumption: patterns from the multinational GENACIS project. Addiction, 2009, 104(9): 1487-1500. doi:10.1111/j.1360-0443.2009.02696.x. pmid: 19686518
[53]	Neyrolles O, Quintana-Murci L. Sexual inequality in tuberculosis. PLoS Med, 2009, 6(12):e1000199. doi:10.1371/journal.pmed.1000199.
[54]	Li T, Yan X, Du X, et al. Extrapulmonary tuberculosis in China: a national survey. Int J Infect Dis, 2023, 128: 69-77. doi:10.1016/j.ijid.2022.12.005.
[55]	Yuen CM, Szkwarko D, Dubois MM, et al. Tuberculosis care models for children and adolescents: a scoping review. Bull World Health Organ, 2022, 100(12): 777-788 L. doi:10.2471/BLT.22.288447.
[56]	Li T, Shewade HD, Soe KT, et al. Under-reporting of diagnosed tuberculosis to the national surveillance system in China: an inventory study in nine counties in 2015. BMJ Open, 2019, 9(1): e021529. doi:10.1136/bmjopen-2018-021529.
[57]	Li T, Chen W, Zhao Y, et al. Underreporting of Notifiable Pulmonary Tuberculosis Cases to the National Tuberculosis Information Management System-China, 2015. China CDC Weekly, 2020, 2(12): 185-189.
[58]	Li T, Yang L, Smith-Jeffcoat SE, et al. Assessing the Quality of Reporting to China’s National TB Surveillance Systems. Int J Environ Res Public Health, 2021, 18(5): 2264. doi:10.3390/ijerph18052264.
[59]	Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med, 2012, 367(4):348-361. doi:10.1056/NEJMra1008049.
[60]	Rajendran P, Thomas SV, Balaji S, et al. Paediatric pulmonary disease-are we diagnosing it right?. Front Pediatr, 2024, 12:1370687. doi:10.3389/fped.2024.1370687.
[61]	张春华, 陈伟. 儿童结核病流行现状与经济负担研究进展. 结核与肺部疾病杂志, 2022, 3(5):405-409. doi:10.19983/j.issn.2096-8493.20220131.
[62]	中华人民共和国国家卫生健康委员会. 国家免疫规划疫苗儿童免疫程序及说明(2021年版). 中国病毒病杂志, 2021, 11(4):241-245. doi:10.16505/j.2095-0136.2021.0021.
[63]	Wang L, Wang W. Temporal Trends in Notification and Mortality of Tuberculosis in China, 2004—2019: A Joinpoint and Age-Period-Cohort Analysis. Int J Environ Res Public Health, 2021, 18(11):5607. doi:10.3390/ijerph18115607.
[64]	滕人聪, 李涛, 李玉红, 等. 2015—2021年全国65岁及以上老年肺结核患者登记情况分析. 中国防痨杂志, 2023, 45(4): 367-371. doi:10.19982/j.issn.1000-6621.20220494.
[65]	Li T, Li J, Du X, et al. Age-Specific Pulmonary Tuberculosis Notification Rates-China, 2008—2018. China CDC Weekly, 2022, 4(38): 841-846. doi:10.46234/ccdcw2022.176.
[66]	张灿有, 陈卉, 张慧, 等. 2011—2020年全国65岁及以上老年人肺结核报告发病情况分析. 中华疾病控制杂志, 2022, 26(11):1252-1258. doi:10.16462/j.cnki.zhjbkz.2022.11.003.
[67]	Hochberg NS, Horsburgh CR Jr. Prevention of tuberculosis in older adults in the United States: obstacles and opportunities. Clin Infect Dis, 2013, 56(9):1240-1247. doi:10.1093/cid/cit027. pmid: 23362286
[68]	国家统计局. 中国统计年鉴2023. 北京: 中国统计出版社, 2024.
[69]	United Nations,Department of Economic and Social Affairs Population Division of Unitea Nations. World Population Prospects 2024. New York: United Nations, 2024.
[70]	王黎霞. 织密五张患者发现网精准掌握结核病疫情. 中国防痨杂志, 2022, 44(1): 1-3. doi:10.19982/j.issn.1000-6621.20210673.
[71]	Zhang M, Wang T, Hou S, et al. An Outbreak of Multidrug-Resistant Tuberculosis in a Secondary School—Hubei Province, 2019. China CDC Weekly, 2019, 1(5): 67-69. doi:10.46234/ccdcw2019.020.
[72]	Li D, Peng X, Hou S, et al. A Tuberculosis Outbreak During the COVID-19 Pandemic—Hubei Province, China, 2020. China CDC Weekly, 2021, 3(26): 562-565. doi:10.46234/ccdcw2021.145.
[73]	Wang S, Cui Y, Liu N, et al. A Tuberculosis Outbreak at a School—Xinjiang Uygur Autonomous Region, China, 2019. China CDC Weekly, 2020, 2(46): 881-883. doi:10.46234/ccdcw2020.240.
[74]	范君, 苏倩, 陈健, 等. 重庆市一起学校肺结核聚集性疫情调查分析. 中国防痨杂志, 2022, 44(8): 792-796. doi:10.19982/j.issn.1000-6621.20220099.
[75]	常俊丽, 张建宏, 章瑛, 等. 一起学校利福平耐药肺结核聚集性疫情的调查分析. 中国防痨杂志, 2021, 43(7): 751-754. doi:10.3969/j.issn.1000-6621.2021.07.019.
[76]	王大宽, 何翼君, 刘自森, 等. 一起校园肺结核疫情的流行病学调查分析. 中国防痨杂志, 2021, 43(11): 1194-1198. doi:10.3969/j.issn.1000-6621.2021.11.015.
[77]	中华人民共和国国家卫生和计划生育委员会办公厅, 中华人民共和国教育部办公厅. 学校结核病防控工作规范(2017版). 国卫办疾控发〔2017〕22号. 2017-06-26.
[78]	白丽琼. 是危机,还是机遇——湖南省桃江县发生学校结核病聚集性疫情的思考. 实用预防医学, 2018, 25(1):1-2,61. doi:10.3969/j.issn.1006-3110.2018.01.001.
[79]	成君, 刘剑君. 我国学校结核病疫情监测和预警的现状与进展. 中国防痨杂志, 2020, 42(5): 436-441. doi:10.3969/j.issn.1000-6621.2020.05.005.
[80]	陈卉, 张灿有, 张慧, 等. 2004—2021年全国学校肺结核疫情分析. 中国防痨杂志, 2022, 44(8): 768-776. doi:10.19982/j.issn.1000-6621.20220200.
[81]	李涛, 成诗明, 杜昕. 全国结核病防治工作模式与患者发现和治疗管理水平分析. 中国防痨杂志, 2015, 37(1): 30-34. doi:10.3969/j.issn.1000-6621.2015.01.007.
[82]	王前, 周林, 刘二勇, 等. 我国县级结核病定点医疗机构结核病诊断能力现况调查研究. 中国防痨杂志, 2020, 42(9): 926-930. doi:10.3969/j.issn.1000-6621.2020.09.008.
[83]	刘二勇, 王前, 周林, 等. 我国部分地区病原学检测阴性肺结核诊断质量现状分析. 中国防痨杂志, 2020, 42(9): 916-920. doi:10.3969/j.issn.1000-6621.2020.09.006.
[84]	杨春龙, 周林, 陈明亭. 《病原学检测阴性肺结核诊断流程(T/CHATA 008—2020)》解读. 中国防痨杂志, 2021, 43(11): 1116-1119. doi:10.3969/j.issn.1000-6621.2021.11.003.
[85]	General Assembly of the United Nations. Political Declaration of the High-Level Meeting on the Fight against Tuberculosis:draft resolution/submitted by the President of the General Assembly. New York: General Assembly of the United Nations, 2023.

年份	报告发病例数					报告发病率(/10万)		报告病原学阳性率 (%)^e
年份	肺结核总数	病原学阳性^a	病原学阴性^b	无病原学结果^c	结核性胸膜炎^d	肺结核	肺结核 (含结核性胸膜炎)	报告病原学阳性率 (%)^e
1997	418234	135130	109288	173816	-	34.69	-	55.29
1998	490795	161887	133475	195433	-	39.21	-	54.81
1999	518095	161937	146325	209833	-	41.72	-	52.53
2000	543035	167947	149804	225284	-	43.75	-	52.85
2001	570527	171256	162940	236331	-	44.89	-	51.24
2002	583570	167271	177327	238972	-	43.58	-	48.54
2003	706087	235716	204412	265959	-	52.36	-	53.56
2004	970279	350843	281806	337630	-	74.64	-	55.46
2005	1259308	546285	412541	300482	5726	96.88	97.32	56.97
2006	1127571	444555	416716	266300	21494	86.23	87.88	51.62
2007	1163959	432821	457218	273920	28718	88.55	90.73	48.63
2008	1169540	440782	464439	264319	33365	88.52	91.04	48.69
2009	1076938	481500	458646	136792	39031	81.09	84.03	51.22
2010	991350	458294	433559	99497	34561	74.27	76.86	51.39
2011	953275	401667	464999	86609	33494	71.09	73.59	46.35
2012	951508	348773	520961	81774	35270	70.62	73.24	40.10
2013	904434	309330	515460	79644	35491	66.80	69.42	37.50
2014	889381	272424	532157	84800	38125	65.63	68.44	33.86
2015	864015	247168	535914	80933	39149	63.42	66.29	31.56
2016	836236	237942	523941	74353	40076	61.00	63.93	31.23
2017	835193	244302	516967	73924	42711	60.53	63.62	32.09
2018	823342	277439	486826	59077	45711	59.27	62.56	36.30
2019	775764	349307	351599	74858	-	-	55.55	49.84
2020	670538	347610	269472	53456	-	-	47.76	56.33
2021	639548	352381	236284	50883	-	-	45.37	59.86
2022	560847	323476	200148	37223	-	-	39.80	61.78
2023	613091	392569	192618	27904	-	-	43.49	67.08